In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome
Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA)...
Saved in:
| Published in | Metabolism, clinical and experimental Vol. 61; no. 5; pp. 680 - 688 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
New York, NY
Elsevier Inc
01.05.2012
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0026-0495 1532-8600 1532-8600 |
| DOI | 10.1016/j.metabol.2011.10.003 |
Cover
| Abstract | Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA) was also explored. Seven healthy normal-weight subjects (male/female [M/F], 3/4; age, 27.4 ± 10.9 years; body mass index [BMI], 21.9 ± 2.2 kg/m2), 7 obese subjects without MetSyn (M/F, 1/6; age, 48.0 ± 8.0 years; BMI, 34.5 ± 2.3 kg/m2), and 7 with MetSyn (M/F, 3/4; age, 48.0 ± 10.7 years; BMI, 33.4 ± 2.9 kg/m2) were recruited. Body composition and cardiometabolic functions (blood pressure, glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein, ADMA) were measured. A frequent sampling intravenous glucose tolerance test was performed to measure Si. A novel stable isotopic method was used to measure in vivo rates of NO production. The NO production was lower in obese subjects with MetSyn compared with normal-weight subjects and obese subjects without MetSyn. Similarly, Si was significantly lower in obesity, both without and with MetSyn, compared with the control group. A significant direct association was found between NO synthesis and Si (ρ = 0.47, P = .03). Circulating levels of ADMA were significantly higher in the obese group with MetSyn. A nonsignificant negative trend between ADMA and NO synthesis was observed. The association between Si and NO production suggests a close mechanistic link between endothelial function and insulin signaling. The results may be highly informative for the development of controlled longitudinal interventions to improve endothelial and metabolic regulation. |
|---|---|
| AbstractList | Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA) was also explored. Seven healthy normal-weight subjects (male/female [M/F], 3/4; age, 27.4 ± 10.9 years; body mass index [BMI], 21.9 ± 2.2 kg/m²), 7 obese subjects without MetSyn (M/F, 1/6; age, 48.0 ± 8.0 years; BMI, 34.5 ± 2.3 kg/m²), and 7 with MetSyn (M/F, 3/4; age, 48.0 ± 10.7 years; BMI, 33.4 ± 2.9 kg/m²) were recruited. Body composition and cardiometabolic functions (blood pressure, glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein, ADMA) were measured. A frequent sampling intravenous glucose tolerance test was performed to measure Si. A novel stable isotopic method was used to measure in vivo rates of NO production. The NO production was lower in obese subjects with MetSyn compared with normal-weight subjects and obese subjects without MetSyn. Similarly, Si was significantly lower in obesity, both without and with MetSyn, compared with the control group. A significant direct association was found between NO synthesis and Si (ρ = 0.47, P = .03). Circulating levels of ADMA were significantly higher in the obese group with MetSyn. A nonsignificant negative trend between ADMA and NO synthesis was observed. The association between Si and NO production suggests a close mechanistic link between endothelial function and insulin signaling. The results may be highly informative for the development of controlled longitudinal interventions to improve endothelial and metabolic regulation. Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA) was also explored. Seven healthy normal-weight subjects (male/female [M/F], 3/4; age, 27.4 ± 10.9 years; body mass index [BMI], 21.9 ± 2.2 kg/m2), 7 obese subjects without MetSyn (M/F, 1/6; age, 48.0 ± 8.0 years; BMI, 34.5 ± 2.3 kg/m2), and 7 with MetSyn (M/F, 3/4; age, 48.0 ± 10.7 years; BMI, 33.4 ± 2.9 kg/m2) were recruited. Body composition and cardiometabolic functions (blood pressure, glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein, ADMA) were measured. A frequent sampling intravenous glucose tolerance test was performed to measure Si. A novel stable isotopic method was used to measure in vivo rates of NO production. The NO production was lower in obese subjects with MetSyn compared with normal-weight subjects and obese subjects without MetSyn. Similarly, Si was significantly lower in obesity, both without and with MetSyn, compared with the control group. A significant direct association was found between NO synthesis and Si (ρ = 0.47, P = .03). Circulating levels of ADMA were significantly higher in the obese group with MetSyn. A nonsignificant negative trend between ADMA and NO synthesis was observed. The association between Si and NO production suggests a close mechanistic link between endothelial function and insulin signaling. The results may be highly informative for the development of controlled longitudinal interventions to improve endothelial and metabolic regulation. Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA) was also explored. Seven healthy normal-weight subjects (male/female [M/F], 3/4; age, 27.4 ± 10.9 years; body mass index [BMI], 21.9 ± 2.2 kg/m(2)), 7 obese subjects without MetSyn (M/F, 1/6; age, 48.0 ± 8.0 years; BMI, 34.5 ± 2.3 kg/m(2)), and 7 with MetSyn (M/F, 3/4; age, 48.0 ± 10.7 years; BMI, 33.4 ± 2.9 kg/m(2)) were recruited. Body composition and cardiometabolic functions (blood pressure, glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein, ADMA) were measured. A frequent sampling intravenous glucose tolerance test was performed to measure Si. A novel stable isotopic method was used to measure in vivo rates of NO production. The NO production was lower in obese subjects with MetSyn compared with normal-weight subjects and obese subjects without MetSyn. Similarly, Si was significantly lower in obesity, both without and with MetSyn, compared with the control group. A significant direct association was found between NO synthesis and Si (ρ = 0.47, P = .03). Circulating levels of ADMA were significantly higher in the obese group with MetSyn. A nonsignificant negative trend between ADMA and NO synthesis was observed. The association between Si and NO production suggests a close mechanistic link between endothelial function and insulin signaling. The results may be highly informative for the development of controlled longitudinal interventions to improve endothelial and metabolic regulation.Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA) was also explored. Seven healthy normal-weight subjects (male/female [M/F], 3/4; age, 27.4 ± 10.9 years; body mass index [BMI], 21.9 ± 2.2 kg/m(2)), 7 obese subjects without MetSyn (M/F, 1/6; age, 48.0 ± 8.0 years; BMI, 34.5 ± 2.3 kg/m(2)), and 7 with MetSyn (M/F, 3/4; age, 48.0 ± 10.7 years; BMI, 33.4 ± 2.9 kg/m(2)) were recruited. Body composition and cardiometabolic functions (blood pressure, glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein, ADMA) were measured. A frequent sampling intravenous glucose tolerance test was performed to measure Si. A novel stable isotopic method was used to measure in vivo rates of NO production. The NO production was lower in obese subjects with MetSyn compared with normal-weight subjects and obese subjects without MetSyn. Similarly, Si was significantly lower in obesity, both without and with MetSyn, compared with the control group. A significant direct association was found between NO synthesis and Si (ρ = 0.47, P = .03). Circulating levels of ADMA were significantly higher in the obese group with MetSyn. A nonsignificant negative trend between ADMA and NO synthesis was observed. The association between Si and NO production suggests a close mechanistic link between endothelial function and insulin signaling. The results may be highly informative for the development of controlled longitudinal interventions to improve endothelial and metabolic regulation. Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA) was also explored. Seven healthy normal-weight subjects (male/female [M/F], 3/4; age, 27.4 ± 10.9 years; body mass index [BMI], 21.9 ± 2.2 kg/m(2)), 7 obese subjects without MetSyn (M/F, 1/6; age, 48.0 ± 8.0 years; BMI, 34.5 ± 2.3 kg/m(2)), and 7 with MetSyn (M/F, 3/4; age, 48.0 ± 10.7 years; BMI, 33.4 ± 2.9 kg/m(2)) were recruited. Body composition and cardiometabolic functions (blood pressure, glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein, ADMA) were measured. A frequent sampling intravenous glucose tolerance test was performed to measure Si. A novel stable isotopic method was used to measure in vivo rates of NO production. The NO production was lower in obese subjects with MetSyn compared with normal-weight subjects and obese subjects without MetSyn. Similarly, Si was significantly lower in obesity, both without and with MetSyn, compared with the control group. A significant direct association was found between NO synthesis and Si (ρ = 0.47, P = .03). Circulating levels of ADMA were significantly higher in the obese group with MetSyn. A nonsignificant negative trend between ADMA and NO synthesis was observed. The association between Si and NO production suggests a close mechanistic link between endothelial function and insulin signaling. The results may be highly informative for the development of controlled longitudinal interventions to improve endothelial and metabolic regulation. Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA) was also explored. Seven healthy normal-weight subjects (male/female [M/F], 3/4; age, 27.4 plus or minus 10.9 years; body mass index [BMI], 21.9 plus or minus 2.2 kg/m2), 7 obese subjects without MetSyn (M/F, 1/6; age, 48.0 plus or minus 8.0 years; BMI, 34.5 plus or minus 2.3 kg/m2), and 7 with MetSyn (M/F, 3/4; age, 48.0 plus or minus 10.7 years; BMI, 33.4 plus or minus 2.9 kg/m2) were recruited. Body composition and cardiometabolic functions (blood pressure, glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein, ADMA) were measured. A frequent sampling intravenous glucose tolerance test was performed to measure Si. A novel stable isotopic method was used to measure in vivo rates of NO production. The NO production was lower in obese subjects with MetSyn compared with normal-weight subjects and obese subjects without MetSyn. Similarly, Si was significantly lower in obesity, both without and with MetSyn, compared with the control group. A significant direct association was found between NO synthesis and Si ( rho = 0.47, P = .03). Circulating levels of ADMA were significantly higher in the obese group with MetSyn. A nonsignificant negative trend between ADMA and NO synthesis was observed. The association between Si and NO production suggests a close mechanistic link between endothelial function and insulin signaling. The results may be highly informative for the development of controlled longitudinal interventions to improve endothelial and metabolic regulation. Abstract Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity (Si) in obese subjects with and without MetSyn was evaluated. The relationship between NO production and asymmetric dimethylarginine (ADMA) was also explored. Seven healthy normal-weight subjects (male/female [M/F], 3/4; age, 27.4 ± 10.9 years; body mass index [BMI], 21.9 ± 2.2 kg/m2 ), 7 obese subjects without MetSyn (M/F, 1/6; age, 48.0 ± 8.0 years; BMI, 34.5 ± 2.3 kg/m2 ), and 7 with MetSyn (M/F, 3/4; age, 48.0 ± 10.7 years; BMI, 33.4 ± 2.9 kg/m2 ) were recruited. Body composition and cardiometabolic functions (blood pressure, glucose, insulin, triglycerides, total cholesterol, high-density lipoprotein, ADMA) were measured. A frequent sampling intravenous glucose tolerance test was performed to measure Si. A novel stable isotopic method was used to measure in vivo rates of NO production. The NO production was lower in obese subjects with MetSyn compared with normal-weight subjects and obese subjects without MetSyn. Similarly, Si was significantly lower in obesity, both without and with MetSyn, compared with the control group. A significant direct association was found between NO synthesis and Si ( ρ = 0.47, P = .03). Circulating levels of ADMA were significantly higher in the obese group with MetSyn. A nonsignificant negative trend between ADMA and NO synthesis was observed. The association between Si and NO production suggests a close mechanistic link between endothelial function and insulin signaling. The results may be highly informative for the development of controlled longitudinal interventions to improve endothelial and metabolic regulation. |
| Author | Bluck, Les J.C. Siervo, Mario |
| Author_xml | – sequence: 1 givenname: Mario surname: Siervo fullname: Siervo, Mario – sequence: 2 givenname: Les J.C. surname: Bluck fullname: Bluck, Les J.C. email: Les.Bluck@mrc-hnr.cam.ac.uk |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25850080$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22146092$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNktuKFDEQhoOsuAd9BKVvBC92xkq60wdERRYPCwteqNchna5xauxOdpP0aL-CT23aGRUWZPYqRfj-vyqp_5QdWWeRsccclhx4-XyzHDDq1vVLAZynuyVAfo-dcJmLRV0CHLETAFEuoGjkMTsNYQMAVVWXD9ixELwooREn7Oelzba0dZml6Mlk7gd1mIXJxjUGCucZ2TD2ZLOANlCkLcXpPNO2y3SYhjTCLOooFeup1_4rWbKYRJlrMSSjsd2giSH7TnHtxvhbOdfZfvqkTs067wZ8yO6vdB_w0f48Y1_evf188WFx9fH95cWbq4WRFcQFyk63slpBegM3vCnzuqhKKXRe667Ftqu4ERJ0hQ02RV0VvDWgm9pAkwusV_kZe7bzvfbuZsQQ1UDBYN9ri24Mild5LmWRi-IwCnlRcw5wF5SnTRSi4Al9skfHdsBOXXsatJ_Un60k4Oke0MHofuW1NRT-cbKWADUkTu44410IHld_EQ5zw1Jt1P6f1ZyS-TqlJOle3NIZijqSs9Fr6g-qX-_UmJa0JfQqGEJrsCOfdq06RwcdXt1yMClilJ76DScMGzd6mxKguApCgfo053iO8fzTeSHqZPDy_wZ3GOAX_DUGVw |
| CitedBy_id | crossref_primary_10_1159_000371557 crossref_primary_10_1016_j_tjnut_2023_12_002 crossref_primary_10_1177_1535370220959738 crossref_primary_10_23736_S0392_9590_18_04017_8 crossref_primary_10_1007_s00726_018_2567_x crossref_primary_10_1080_07435800_2016_1197933 crossref_primary_10_1113_JP271836 crossref_primary_10_1371_journal_pone_0254577 crossref_primary_10_3390_jcm12165230 crossref_primary_10_1016_j_dsx_2012_09_012 crossref_primary_10_1080_1744666X_2019_1620601 crossref_primary_10_2337_db13_0542 crossref_primary_10_1038_jhh_2014_48 crossref_primary_10_26442_SG29089 |
| Cites_doi | 10.1016/S0140-6736(96)07631-3 10.1681/ASN.2007040461 10.1007/BF00280883 10.1016/j.numecd.2010.10.003 10.1097/HJH.0b013e3283487806 10.1016/j.clinbiochem.2008.08.076 10.1161/01.CIR.101.15.1780 10.1016/j.metabol.2009.12.023 10.1161/ATVBAHA.107.159228 10.2307/2530051 10.1097/01.hjh.0000239294.17636.27 10.1016/S0140-6736(05)66378-7 10.1161/CIRCULATIONAHA.109.192644 10.1016/S0140-6736(03)13177-7 10.1186/1471-2458-9-88 10.1007/s00125-002-1009-0 10.1016/j.amjcard.2007.07.053 10.1152/japplphysiol.00660.2006 10.1016/j.atherosclerosis.2006.02.032 10.1007/s00125-009-1313-z 10.1177/1358863X08095154 10.2337/dc06-2142 10.1210/er.2007-0006 10.1186/1475-2840-8-27 10.1177/1358863X07084200 10.1016/j.metabol.2004.07.001 10.1111/j.1365-2362.2007.01781.x 10.1161/CIRCULATIONAHA.107.690016 10.1373/clinchem.2007.093575 10.1152/ajpendo.1979.236.6.E667 10.1016/S0140-6736(05)67483-1 10.1046/j.1365-2796.2002.01036.x 10.1016/j.phrs.2009.07.016 10.1161/CIRCULATIONAHA.107.748574 10.1042/CS20080218 10.1161/CIRCULATIONAHA.105.563213 10.1002/rcm.3841 10.1055/s-2007-985898 10.1093/eurheartj/ehp061 10.1016/j.niox.2008.08.005 10.1161/01.ATV.20.9.2039 10.2337/db05-1373 10.2337/diabetes.51.4.1138 10.1016/j.metabol.2004.09.015 10.1002/rcm.3195 10.1210/jc.2004-0631 10.1016/j.atherosclerosis.2007.06.008 10.1016/j.beem.2006.09.007 10.1161/CIRCULATIONAHA.108.765701 10.2337/diabetes.52.3.795 10.1042/cs1000161 10.1016/j.metabol.2004.06.026 10.1046/j.1464-5491.2003.00869.x |
| ContentType | Journal Article |
| Copyright | 2012 Elsevier Inc. Elsevier Inc. 2015 INIST-CNRS Copyright © 2012 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2012 Elsevier Inc. – notice: Elsevier Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2012 Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TS 7S9 L.6 |
| DOI | 10.1016/j.metabol.2011.10.003 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Physical Education Index AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Physical Education Index AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE Physical Education Index |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1532-8600 |
| EndPage | 688 |
| ExternalDocumentID | 22146092 25850080 10_1016_j_metabol_2011_10_003 S0026049511003428 1_s2_0_S0026049511003428 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Medical Research Council grantid: MC_UP_A090_1005 |
| GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYJJ AAYWO ABBQC ABDPE ABFNM ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACIEU ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AEVXI AFFNX AFJKZ AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HX~ HZ~ IHE J1W J5H K-O KOM L7B LZ1 M29 M41 MO0 MVM N9A O-L O9- OAUVE OB0 OHT ON- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K UAP UHS WUQ X7M Z5R ZGI ~G- ~KM AACTN AFCTW AFKWA AJOXV AMFUW PKN RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU DOVZS EFLBG G8K LCYCR ZA5 AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7TS 7S9 L.6 |
| ID | FETCH-LOGICAL-c570t-e5dab57f02141c1963847652a38adbebd71c250a7e9e948741bc0a98c0932e8f3 |
| IEDL.DBID | AIKHN |
| ISSN | 0026-0495 1532-8600 |
| IngestDate | Fri Sep 05 07:11:46 EDT 2025 Thu Sep 04 23:29:20 EDT 2025 Fri Sep 05 10:37:53 EDT 2025 Mon Jul 21 06:07:34 EDT 2025 Mon Jul 21 09:15:00 EDT 2025 Tue Jul 01 03:16:34 EDT 2025 Thu Apr 24 23:08:22 EDT 2025 Fri Feb 23 02:21:19 EST 2024 Sun Feb 23 10:20:05 EST 2025 Tue Aug 26 19:44:49 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | Endocrinopathy Human Obesity Pancreatic hormone Nutrition disorder Metabolic diseases Cardiovascular disease Metabolic syndrome Insulin In vivo Nitric oxide Endocrinology Nutritional status |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2012 Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c570t-e5dab57f02141c1963847652a38adbebd71c250a7e9e948741bc0a98c0932e8f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 22146092 |
| PQID | 1010494241 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_1733554324 proquest_miscellaneous_1034811004 proquest_miscellaneous_1010494241 pubmed_primary_22146092 pascalfrancis_primary_25850080 crossref_primary_10_1016_j_metabol_2011_10_003 crossref_citationtrail_10_1016_j_metabol_2011_10_003 elsevier_sciencedirect_doi_10_1016_j_metabol_2011_10_003 elsevier_clinicalkeyesjournals_1_s2_0_S0026049511003428 elsevier_clinicalkey_doi_10_1016_j_metabol_2011_10_003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-05-01 |
| PublicationDateYYYYMMDD | 2012-05-01 |
| PublicationDate_xml | – month: 05 year: 2012 text: 2012-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States |
| PublicationTitle | Metabolism, clinical and experimental |
| PublicationTitleAlternate | Metabolism |
| PublicationYear | 2012 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Riccardi, Aggett, Brighenti, Delzenne, Frayn, Nieuwenhuizen (bb0070) 2004; 43 Doshi, McDowell, Goodfellow, Stabler, Boger, Allen (bb0200) 2005; 54 Kelly, Thelen, Kaiser, Gonzalez-Campoy, Bank (bb0215) 2007; 12 Yilmaz, Sonmez, Saglam, Qureshi, Carrero, Caglar (bb0185) 2008; 19 Fard, Tuck, Donis, Sciacca, Di Tullio, Wu (bb0235) 2000; 20 Garg (bb0020) 2004; 89 Conover, Iman (bb0120) 1982; 38 Wheatcroft, Williams, Shah, Kearney (bb0085) 2003; 20 Campuzano, Moya, Garcia-Lleda, Tomas, Ruiz, Megas (bb0255) 2006; 24 Antoniades, Shirodaria, Leeson, Antonopoulos, Warrick, Van-Assche (bb0225) 2009; 30 Beckman, Goldfine, Dunaif, Gerhard-Herman, Creager (bb0160) 2007; 30 Maas, Schwedhelm, Kahl, Li, Benndorf, Luneburg (bb0180) 2008; 54 Alberti, Eckel, Grundy, Zimmet, Cleeman, Donato (bb0095) 2009; 120 Zahedi Asl, Ghasemi, Azizi (bb0275) 2008; 41 Kahn (bb0030) 2003; 46 Hamburg, Keyes, Larson, Vasan, Schnabel, Pryde (bb0170) 2008; 117 Bergman, Ider, Bowden, Cobelli (bb0100) 1979; 236 Despres, Lemieux, Bergeron, Pibarot, Mathieu, Larose (bb0010) 2008; 28 Olszanecka-Glinianowicz, Zahorska-Markiewicz, Janowska, Zurakowski (bb0270) 2004; 53 Juonala, Viikari, Alfthan, Marniemi, Kahonen, Taittonen (bb0210) 2007; 116 Reyes-Soffer, Holleran, Di Tullio, Homma, Boden-Albala, Ramakrishnan (bb0060) 2010; 59 Savvidou, Hingorani, Tsikas, Frolich, Vallance, Nicolaides (bb0240) 2003; 361 O'Kane, Jackson, Ferro (bb0135) 2008; 196 Avogaro, Toffolo, Kiwanuka, de Kreutzenberg, Tessari, Cobelli (bb0155) 2003; 52 Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (bb0115) 1985; 28 Wendelhag, Fagerberg, Hulthe, Bokemark, Wikstrand (bb0145) 2002; 252 Eid, Arnesen, Hjerkinn, Lyberg, Lyberg, Seljeflot (bb0245) 2004; 53 Barrett, Eggleston, Inyard, Wang, Li, Chai (bb0045) 2009; 52 Eckel, Grundy, Zimmet (bb0075) 2005; 365 Ardigo, Stuehlinger, Franzini, Valtuena, Piatti, Pachinger (bb0195) 2007; 37 Guh, Zhang, Bansback, Amarsi, Birmingham, Anis (bb0015) 2009; 9 Haslam, James (bb0005) 2005; 366 Clerk, Rattigan, Clark (bb0130) 2002; 51 Ganong (bb0035) 1999 Jackson, Waterhouse, Bluck (bb0110) 2007; 21 Halcox, Donald, Ellins, Witte, Shipley, Brunner (bb0250) 2009; 119 Balletshofer, Rittig, Enderle, Volk, Maerker, Jacob (bb0165) 2000; 101 Gates, Boucher, Silver, Monahan, Seals (bb0205) 2007; 102 Yudkin (bb0080) 2007; 39 Forte, Copland, Smith, Milne, Sutherland, Benjamin (bb0125) 1997; 349 Clerk, Vincent, Jahn, Liu, Lindner, Barrett (bb0055) 2006; 55 Sesti (bb0025) 2006; 20 Moran, Hutchison, Meyer, Zoungas, Teede (bb0220) 2009; 116 Hamburg, Larson, Vita, Vasan, Keyes, Widlansky (bb0150) 2008; 101 Pope, Karuppiah, Cardounel (bb0175) 2009 Sibal, Agarwal, Schwedhelm, Luneburg, Boger, Home (bb0190) 2009; 8 Muniyappa, Montagnani, Koh, Quon (bb0040) 2007; 28 Jackson, Siervo, Persson, McKenna, Bluck (bb0105) 2008; 22 Boger, Lentz, Bode-Boger, Knapp, Haynes (bb0230) 2001; 100 Gomes, Casella-Filho, Chagas, Tanus-Santos (bb0265) 2008; 19 Cui, Iso, Pi, Kumagai, Yamagishi, Tanigawa (bb0260) 2007; 190 Siervo, Jackson, Bluck (bb0090) 2011; 29 Siervo, Corander, Stranges, Bluck (bb0065) 2011; 21 Title, Lonn, Charbonneau, Fung, Mather, Verma (bb0140) 2008; 13 Kim, Montagnani, Koh, Quon (bb0050) 2006; 113 Yilmaz (10.1016/j.metabol.2011.10.003_bb0185) 2008; 19 Juonala (10.1016/j.metabol.2011.10.003_bb0210) 2007; 116 Cui (10.1016/j.metabol.2011.10.003_bb0260) 2007; 190 Kelly (10.1016/j.metabol.2011.10.003_bb0215) 2007; 12 Boger (10.1016/j.metabol.2011.10.003_bb0230) 2001; 100 Beckman (10.1016/j.metabol.2011.10.003_bb0160) 2007; 30 Clerk (10.1016/j.metabol.2011.10.003_bb0055) 2006; 55 Muniyappa (10.1016/j.metabol.2011.10.003_bb0040) 2007; 28 Jackson (10.1016/j.metabol.2011.10.003_bb0110) 2007; 21 Clerk (10.1016/j.metabol.2011.10.003_bb0130) 2002; 51 Haslam (10.1016/j.metabol.2011.10.003_bb0005) 2005; 366 Matthews (10.1016/j.metabol.2011.10.003_bb0115) 1985; 28 Siervo (10.1016/j.metabol.2011.10.003_bb0090) 2011; 29 Olszanecka-Glinianowicz (10.1016/j.metabol.2011.10.003_bb0270) 2004; 53 Zahedi Asl (10.1016/j.metabol.2011.10.003_bb0275) 2008; 41 Avogaro (10.1016/j.metabol.2011.10.003_bb0155) 2003; 52 Savvidou (10.1016/j.metabol.2011.10.003_bb0240) 2003; 361 Antoniades (10.1016/j.metabol.2011.10.003_bb0225) 2009; 30 Riccardi (10.1016/j.metabol.2011.10.003_bb0070) 2004; 43 Forte (10.1016/j.metabol.2011.10.003_bb0125) 1997; 349 Wendelhag (10.1016/j.metabol.2011.10.003_bb0145) 2002; 252 Gates (10.1016/j.metabol.2011.10.003_bb0205) 2007; 102 Hamburg (10.1016/j.metabol.2011.10.003_bb0170) 2008; 117 Garg (10.1016/j.metabol.2011.10.003_bb0020) 2004; 89 Fard (10.1016/j.metabol.2011.10.003_bb0235) 2000; 20 Pope (10.1016/j.metabol.2011.10.003_bb0175) 2009 Gomes (10.1016/j.metabol.2011.10.003_bb0265) 2008; 19 Sesti (10.1016/j.metabol.2011.10.003_bb0025) 2006; 20 Yudkin (10.1016/j.metabol.2011.10.003_bb0080) 2007; 39 Bergman (10.1016/j.metabol.2011.10.003_bb0100) 1979; 236 Kim (10.1016/j.metabol.2011.10.003_bb0050) 2006; 113 Barrett (10.1016/j.metabol.2011.10.003_bb0045) 2009; 52 Eid (10.1016/j.metabol.2011.10.003_bb0245) 2004; 53 Ardigo (10.1016/j.metabol.2011.10.003_bb0195) 2007; 37 Title (10.1016/j.metabol.2011.10.003_bb0140) 2008; 13 Campuzano (10.1016/j.metabol.2011.10.003_bb0255) 2006; 24 Balletshofer (10.1016/j.metabol.2011.10.003_bb0165) 2000; 101 Guh (10.1016/j.metabol.2011.10.003_bb0015) 2009; 9 Jackson (10.1016/j.metabol.2011.10.003_bb0105) 2008; 22 Siervo (10.1016/j.metabol.2011.10.003_bb0065) 2011; 21 Moran (10.1016/j.metabol.2011.10.003_bb0220) 2009; 116 Eckel (10.1016/j.metabol.2011.10.003_bb0075) 2005; 365 Despres (10.1016/j.metabol.2011.10.003_bb0010) 2008; 28 Kahn (10.1016/j.metabol.2011.10.003_bb0030) 2003; 46 Conover (10.1016/j.metabol.2011.10.003_bb0120) 1982; 38 Alberti (10.1016/j.metabol.2011.10.003_bb0095) 2009; 120 Hamburg (10.1016/j.metabol.2011.10.003_bb0150) 2008; 101 Halcox (10.1016/j.metabol.2011.10.003_bb0250) 2009; 119 Ganong (10.1016/j.metabol.2011.10.003_bb0035) 1999 Reyes-Soffer (10.1016/j.metabol.2011.10.003_bb0060) 2010; 59 Wheatcroft (10.1016/j.metabol.2011.10.003_bb0085) 2003; 20 Maas (10.1016/j.metabol.2011.10.003_bb0180) 2008; 54 Sibal (10.1016/j.metabol.2011.10.003_bb0190) 2009; 8 Doshi (10.1016/j.metabol.2011.10.003_bb0200) 2005; 54 O'Kane (10.1016/j.metabol.2011.10.003_bb0135) 2008; 196 |
| References_xml | – volume: 120 start-page: 1640 year: 2009 end-page: 1645 ident: bb0095 article-title: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity publication-title: Circulation – volume: 349 start-page: 837 year: 1997 end-page: 842 ident: bb0125 article-title: Basal nitric oxide synthesis in essential hypertension publication-title: Lancet – volume: 54 start-page: 292 year: 2008 end-page: 300 ident: bb0180 article-title: Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia publication-title: Clin Chem – volume: 12 start-page: 311 year: 2007 end-page: 318 ident: bb0215 article-title: Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus publication-title: Vasc Med – volume: 361 start-page: 1511 year: 2003 end-page: 1517 ident: bb0240 article-title: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia publication-title: Lancet – volume: 236 start-page: E667 year: 1979 end-page: E677 ident: bb0100 article-title: Quantitative estimation of insulin sensitivity publication-title: Am J Physiol Endocrinol Metab – volume: 190 start-page: 423 year: 2007 end-page: 428 ident: bb0260 article-title: Metabolic syndrome and urinary cGMP excretion in general population publication-title: Atherosclerosis – volume: 20 start-page: 665 year: 2006 end-page: 679 ident: bb0025 article-title: Pathophysiology of insulin resistance publication-title: Best Pract Res Clin Endocrinol Metab – volume: 113 start-page: 1888 year: 2006 end-page: 1904 ident: bb0050 article-title: Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms publication-title: Circulation – volume: 21 start-page: 1 year: 2011 end-page: 10 ident: bb0065 article-title: Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA) publication-title: Nutr Metab Cardiovasc Dis – volume: 38 start-page: 715 year: 1982 end-page: 724 ident: bb0120 article-title: Analysis of covariance using the rank transformation publication-title: Biometrics – volume: 101 start-page: 82 year: 2008 end-page: 88 ident: bb0150 article-title: Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease publication-title: Am J Cardiol – volume: 19 start-page: 345 year: 2008 end-page: 350 ident: bb0265 article-title: Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome publication-title: Nitric Oxide – volume: 196 start-page: 574 year: 2008 end-page: 579 ident: bb0135 article-title: Whole body nitric oxide production is not decreased in patients with coronary atherosclerosis but is inversely related to plasma homocysteine publication-title: Atherosclerosis – volume: 8 start-page: 27 year: 2009 ident: bb0190 article-title: A study of endothelial function and circulating asymmetric dimethylarginine levels in people with type 1 diabetes without macrovascular disease or microalbuminuria publication-title: Cardiovasc Diabetol – volume: 116 start-page: 761 year: 2009 end-page: 770 ident: bb0220 article-title: A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome publication-title: Clin Sci (Lond) – volume: 59 start-page: 1365 year: 2010 end-page: 1371 ident: bb0060 article-title: Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus publication-title: Metabolism – volume: 13 start-page: 263 year: 2008 end-page: 270 ident: bb0140 article-title: Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome publication-title: Vasc Med – volume: 43 start-page: II7 year: 2004 end-page: II46 ident: bb0070 article-title: PASSCLAIM—body weight regulation, insulin sensitivity and diabetes risk publication-title: Eur J Nutr – volume: 54 start-page: 351 year: 2005 end-page: 360 ident: bb0200 article-title: Relationship between publication-title: Metabolism – volume: 100 start-page: 161 year: 2001 end-page: 167 ident: bb0230 article-title: Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans publication-title: Clin Sci (Lond) – volume: 22 start-page: 4158 year: 2008 end-page: 4164 ident: bb0105 article-title: A novel derivative for the assessment of urinary and salivary nitrate using gas chromatography/mass spectrometry publication-title: Rapid Commun Mass Spectrom – volume: 20 start-page: 2039 year: 2000 end-page: 2044 ident: bb0235 article-title: Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes publication-title: Arterioscler Thromb Vasc Biol – volume: 21 start-page: 3123 year: 2007 end-page: 3128 ident: bb0110 article-title: A single glucose derivative suitable for gas chromatography/mass spectrometry and gas chromatography/combustion/isotope ratio mass spectrometry publication-title: Rapid Commun Mass Spectrom – volume: 29 start-page: 1515 year: 2011 end-page: 1527 ident: bb0090 article-title: In vivo nitric oxide synthesis is reduced in obese subjects with metabolic syndrome: application of a novel stable isotopic method publication-title: J of Hypertension – year: 1999 ident: bb0035 article-title: Review of medical physiology – volume: 19 start-page: 388 year: 2008 end-page: 395 ident: bb0185 article-title: ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction publication-title: J Am Soc Nephrol – volume: 52 start-page: 752 year: 2009 end-page: 764 ident: bb0045 article-title: The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action publication-title: Diabetologia – volume: 119 start-page: 1005 year: 2009 end-page: 1012 ident: bb0250 article-title: Endothelial function predicts progression of carotid intima-media thickness publication-title: Circulation – volume: 101 start-page: 1780 year: 2000 end-page: 1784 ident: bb0165 article-title: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance publication-title: Circulation – volume: 30 start-page: 1226 year: 2007 end-page: 1232 ident: bb0160 article-title: Endothelial function varies according to insulin resistance disease type publication-title: Diabetes Care – volume: 24 start-page: 1581 year: 2006 end-page: 1588 ident: bb0255 article-title: Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis publication-title: J Hypertens – volume: 37 start-page: 263 year: 2007 end-page: 269 ident: bb0195 article-title: ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk publication-title: Eur J Clin Invest – volume: 28 start-page: 412 year: 1985 end-page: 419 ident: bb0115 article-title: Homeostasis model assessment: insulin resistance and publication-title: Diabetologia – volume: 116 start-page: 1367 year: 2007 end-page: 1373 ident: bb0210 article-title: Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study publication-title: Circulation – volume: 41 start-page: 1342 year: 2008 end-page: 1347 ident: bb0275 article-title: Serum nitric oxide metabolites in subjects with metabolic syndrome publication-title: Clin Biochem – volume: 39 start-page: 707 year: 2007 end-page: 709 ident: bb0080 article-title: Inflammation, obesity, and the metabolic syndrome publication-title: Horm Metab Res – volume: 30 start-page: 1142 year: 2009 end-page: 1150 ident: bb0225 article-title: Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis publication-title: Eur Heart J – volume: 46 start-page: 3 year: 2003 end-page: 19 ident: bb0030 article-title: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes publication-title: Diabetologia – volume: 53 start-page: 1268 year: 2004 end-page: 1273 ident: bb0270 article-title: Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-α and TNF soluble receptors in women with overweight and obesity publication-title: Metabolism – volume: 28 start-page: 1039 year: 2008 end-page: 1049 ident: bb0010 article-title: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk publication-title: Arterioscler Thromb Vasc Biol – volume: 52 start-page: 795 year: 2003 end-page: 802 ident: bb0155 article-title: L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach publication-title: Diabetes – volume: 53 start-page: 1574 year: 2004 end-page: 1579 ident: bb0245 article-title: Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine publication-title: Metabolism – volume: 51 start-page: 1138 year: 2002 end-page: 1145 ident: bb0130 article-title: Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo publication-title: Diabetes – volume: 9 start-page: 88 year: 2009 ident: bb0015 article-title: The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis publication-title: BMC Public Health – volume: 366 start-page: 1197 year: 2005 end-page: 1209 ident: bb0005 article-title: Obesity publication-title: Lancet – volume: 117 start-page: 2467 year: 2008 end-page: 2474 ident: bb0170 article-title: Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study publication-title: Circulation – volume: 102 start-page: 63 year: 2007 end-page: 71 ident: bb0205 article-title: Impaired flow-mediated dilation with age is not explained by publication-title: J Appl Physiol – volume: 365 start-page: 1415 year: 2005 end-page: 1428 ident: bb0075 article-title: The metabolic syndrome publication-title: Lancet – volume: 252 start-page: 305 year: 2002 end-page: 313 ident: bb0145 article-title: Endothelium-dependent flow-mediated vasodilatation, insulin resistance and the metabolic syndrome in 60-year-old men publication-title: J Intern Med – volume: 28 start-page: 463 year: 2007 end-page: 491 ident: bb0040 article-title: Cardiovascular actions of insulin publication-title: Endocr Rev – volume: 20 start-page: 255 year: 2003 end-page: 268 ident: bb0085 article-title: Pathophysiological implications of insulin resistance on vascular endothelial function publication-title: Diabet Med – year: 2009 ident: bb0175 article-title: Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production publication-title: Pharmacol Res – volume: 89 start-page: 4206 year: 2004 end-page: 4210 ident: bb0020 article-title: Regional adiposity and insulin resistance publication-title: J Clin Endocrinol Metab – volume: 55 start-page: 1436 year: 2006 end-page: 1442 ident: bb0055 article-title: Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle publication-title: Diabetes – volume: 349 start-page: 837 year: 1997 ident: 10.1016/j.metabol.2011.10.003_bb0125 article-title: Basal nitric oxide synthesis in essential hypertension publication-title: Lancet doi: 10.1016/S0140-6736(96)07631-3 – volume: 19 start-page: 388 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0185 article-title: ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2007040461 – volume: 28 start-page: 412 year: 1985 ident: 10.1016/j.metabol.2011.10.003_bb0115 article-title: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 21 start-page: 1 year: 2011 ident: 10.1016/j.metabol.2011.10.003_bb0065 article-title: Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA) publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2010.10.003 – volume: 29 start-page: 1515 year: 2011 ident: 10.1016/j.metabol.2011.10.003_bb0090 article-title: In vivo nitric oxide synthesis is reduced in obese subjects with metabolic syndrome: application of a novel stable isotopic method publication-title: J of Hypertension doi: 10.1097/HJH.0b013e3283487806 – volume: 41 start-page: 1342 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0275 article-title: Serum nitric oxide metabolites in subjects with metabolic syndrome publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2008.08.076 – year: 1999 ident: 10.1016/j.metabol.2011.10.003_bb0035 – volume: 101 start-page: 1780 year: 2000 ident: 10.1016/j.metabol.2011.10.003_bb0165 article-title: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance publication-title: Circulation doi: 10.1161/01.CIR.101.15.1780 – volume: 59 start-page: 1365 year: 2010 ident: 10.1016/j.metabol.2011.10.003_bb0060 article-title: Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus publication-title: Metabolism doi: 10.1016/j.metabol.2009.12.023 – volume: 28 start-page: 1039 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0010 article-title: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.159228 – volume: 38 start-page: 715 year: 1982 ident: 10.1016/j.metabol.2011.10.003_bb0120 article-title: Analysis of covariance using the rank transformation publication-title: Biometrics doi: 10.2307/2530051 – volume: 24 start-page: 1581 year: 2006 ident: 10.1016/j.metabol.2011.10.003_bb0255 article-title: Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis publication-title: J Hypertens doi: 10.1097/01.hjh.0000239294.17636.27 – volume: 365 start-page: 1415 year: 2005 ident: 10.1016/j.metabol.2011.10.003_bb0075 article-title: The metabolic syndrome publication-title: Lancet doi: 10.1016/S0140-6736(05)66378-7 – volume: 120 start-page: 1640 year: 2009 ident: 10.1016/j.metabol.2011.10.003_bb0095 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192644 – volume: 361 start-page: 1511 year: 2003 ident: 10.1016/j.metabol.2011.10.003_bb0240 article-title: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia publication-title: Lancet doi: 10.1016/S0140-6736(03)13177-7 – volume: 9 start-page: 88 year: 2009 ident: 10.1016/j.metabol.2011.10.003_bb0015 article-title: The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis publication-title: BMC Public Health doi: 10.1186/1471-2458-9-88 – volume: 46 start-page: 3 year: 2003 ident: 10.1016/j.metabol.2011.10.003_bb0030 article-title: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes publication-title: Diabetologia doi: 10.1007/s00125-002-1009-0 – volume: 101 start-page: 82 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0150 article-title: Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2007.07.053 – volume: 102 start-page: 63 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0205 article-title: Impaired flow-mediated dilation with age is not explained by l-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression publication-title: J Appl Physiol doi: 10.1152/japplphysiol.00660.2006 – volume: 190 start-page: 423 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0260 article-title: Metabolic syndrome and urinary cGMP excretion in general population publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2006.02.032 – volume: 52 start-page: 752 year: 2009 ident: 10.1016/j.metabol.2011.10.003_bb0045 article-title: The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action publication-title: Diabetologia doi: 10.1007/s00125-009-1313-z – volume: 13 start-page: 263 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0140 article-title: Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome publication-title: Vasc Med doi: 10.1177/1358863X08095154 – volume: 30 start-page: 1226 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0160 article-title: Endothelial function varies according to insulin resistance disease type publication-title: Diabetes Care doi: 10.2337/dc06-2142 – volume: 28 start-page: 463 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0040 article-title: Cardiovascular actions of insulin publication-title: Endocr Rev doi: 10.1210/er.2007-0006 – volume: 8 start-page: 27 year: 2009 ident: 10.1016/j.metabol.2011.10.003_bb0190 article-title: A study of endothelial function and circulating asymmetric dimethylarginine levels in people with type 1 diabetes without macrovascular disease or microalbuminuria publication-title: Cardiovasc Diabetol doi: 10.1186/1475-2840-8-27 – volume: 12 start-page: 311 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0215 article-title: Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus publication-title: Vasc Med doi: 10.1177/1358863X07084200 – volume: 53 start-page: 1268 year: 2004 ident: 10.1016/j.metabol.2011.10.003_bb0270 article-title: Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-α and TNF soluble receptors in women with overweight and obesity publication-title: Metabolism doi: 10.1016/j.metabol.2004.07.001 – volume: 37 start-page: 263 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0195 article-title: ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk publication-title: Eur J Clin Invest doi: 10.1111/j.1365-2362.2007.01781.x – volume: 116 start-page: 1367 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0210 article-title: Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.690016 – volume: 54 start-page: 292 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0180 article-title: Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia publication-title: Clin Chem doi: 10.1373/clinchem.2007.093575 – volume: 236 start-page: E667 year: 1979 ident: 10.1016/j.metabol.2011.10.003_bb0100 article-title: Quantitative estimation of insulin sensitivity publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.1979.236.6.E667 – volume: 366 start-page: 1197 year: 2005 ident: 10.1016/j.metabol.2011.10.003_bb0005 article-title: Obesity publication-title: Lancet doi: 10.1016/S0140-6736(05)67483-1 – volume: 252 start-page: 305 year: 2002 ident: 10.1016/j.metabol.2011.10.003_bb0145 article-title: Endothelium-dependent flow-mediated vasodilatation, insulin resistance and the metabolic syndrome in 60-year-old men publication-title: J Intern Med doi: 10.1046/j.1365-2796.2002.01036.x – year: 2009 ident: 10.1016/j.metabol.2011.10.003_bb0175 article-title: Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production publication-title: Pharmacol Res doi: 10.1016/j.phrs.2009.07.016 – volume: 117 start-page: 2467 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0170 article-title: Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.107.748574 – volume: 116 start-page: 761 year: 2009 ident: 10.1016/j.metabol.2011.10.003_bb0220 article-title: A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome publication-title: Clin Sci (Lond) doi: 10.1042/CS20080218 – volume: 113 start-page: 1888 year: 2006 ident: 10.1016/j.metabol.2011.10.003_bb0050 article-title: Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.563213 – volume: 22 start-page: 4158 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0105 article-title: A novel derivative for the assessment of urinary and salivary nitrate using gas chromatography/mass spectrometry publication-title: Rapid Commun Mass Spectrom doi: 10.1002/rcm.3841 – volume: 39 start-page: 707 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0080 article-title: Inflammation, obesity, and the metabolic syndrome publication-title: Horm Metab Res doi: 10.1055/s-2007-985898 – volume: 30 start-page: 1142 year: 2009 ident: 10.1016/j.metabol.2011.10.003_bb0225 article-title: Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis publication-title: Eur Heart J doi: 10.1093/eurheartj/ehp061 – volume: 19 start-page: 345 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0265 article-title: Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome publication-title: Nitric Oxide doi: 10.1016/j.niox.2008.08.005 – volume: 20 start-page: 2039 year: 2000 ident: 10.1016/j.metabol.2011.10.003_bb0235 article-title: Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.20.9.2039 – volume: 55 start-page: 1436 year: 2006 ident: 10.1016/j.metabol.2011.10.003_bb0055 article-title: Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle publication-title: Diabetes doi: 10.2337/db05-1373 – volume: 51 start-page: 1138 year: 2002 ident: 10.1016/j.metabol.2011.10.003_bb0130 article-title: Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo publication-title: Diabetes doi: 10.2337/diabetes.51.4.1138 – volume: 54 start-page: 351 year: 2005 ident: 10.1016/j.metabol.2011.10.003_bb0200 article-title: Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia publication-title: Metabolism doi: 10.1016/j.metabol.2004.09.015 – volume: 21 start-page: 3123 year: 2007 ident: 10.1016/j.metabol.2011.10.003_bb0110 article-title: A single glucose derivative suitable for gas chromatography/mass spectrometry and gas chromatography/combustion/isotope ratio mass spectrometry publication-title: Rapid Commun Mass Spectrom doi: 10.1002/rcm.3195 – volume: 89 start-page: 4206 year: 2004 ident: 10.1016/j.metabol.2011.10.003_bb0020 article-title: Regional adiposity and insulin resistance publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-0631 – volume: 196 start-page: 574 year: 2008 ident: 10.1016/j.metabol.2011.10.003_bb0135 article-title: Whole body nitric oxide production is not decreased in patients with coronary atherosclerosis but is inversely related to plasma homocysteine publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.06.008 – volume: 20 start-page: 665 year: 2006 ident: 10.1016/j.metabol.2011.10.003_bb0025 article-title: Pathophysiology of insulin resistance publication-title: Best Pract Res Clin Endocrinol Metab doi: 10.1016/j.beem.2006.09.007 – volume: 119 start-page: 1005 year: 2009 ident: 10.1016/j.metabol.2011.10.003_bb0250 article-title: Endothelial function predicts progression of carotid intima-media thickness publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.765701 – volume: 52 start-page: 795 year: 2003 ident: 10.1016/j.metabol.2011.10.003_bb0155 article-title: L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach publication-title: Diabetes doi: 10.2337/diabetes.52.3.795 – volume: 100 start-page: 161 year: 2001 ident: 10.1016/j.metabol.2011.10.003_bb0230 article-title: Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans publication-title: Clin Sci (Lond) doi: 10.1042/cs1000161 – volume: 53 start-page: 1574 year: 2004 ident: 10.1016/j.metabol.2011.10.003_bb0245 article-title: Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine publication-title: Metabolism doi: 10.1016/j.metabol.2004.06.026 – volume: 20 start-page: 255 year: 2003 ident: 10.1016/j.metabol.2011.10.003_bb0085 article-title: Pathophysiological implications of insulin resistance on vascular endothelial function publication-title: Diabet Med doi: 10.1046/j.1464-5491.2003.00869.x – volume: 43 start-page: II7 issue: Suppl 2 year: 2004 ident: 10.1016/j.metabol.2011.10.003_bb0070 article-title: PASSCLAIM—body weight regulation, insulin sensitivity and diabetes risk publication-title: Eur J Nutr |
| SSID | ssj0007786 |
| Score | 2.116244 |
| Snippet | Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin sensitivity... Abstract Metabolic syndrome (MetSyn) is associated with impaired endothelial function. Here the association between nitric oxide (NO) production and insulin... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 680 |
| SubjectTerms | Adult Arginine - analogs & derivatives Arginine - blood Biological and medical sciences Blood glucose Blood Glucose - metabolism Blood pressure Blood Pressure - physiology Body composition Body mass body mass index cholesterol Cholesterol, HDL - blood Endocrinology & Metabolism Feeding. Feeding behavior Female females Fundamental and applied biological sciences. Psychology glucose Glucose Tolerance Test glucose tolerance tests high density lipoprotein Hormones Humans insulin insulin resistance Insulin Resistance - physiology Lipids Male males Measurement Medical sciences Metabolic diseases metabolic syndrome Metabolic Syndrome - blood Metabolic Syndrome - metabolism Miscellaneous Nitrates - metabolism nitric oxide Nitric Oxide - biosynthesis Obesity Obesity - blood Obesity - metabolism Other metabolic disorders Saliva - chemistry Saliva - metabolism silicon Trends triacylglycerols Triglycerides - blood Vertebrates: anatomy and physiology, studies on body, several organs or systems Waist Circumference |
| Title | In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0026049511003428 https://www.clinicalkey.es/playcontent/1-s2.0-S0026049511003428 https://dx.doi.org/10.1016/j.metabol.2011.10.003 https://www.ncbi.nlm.nih.gov/pubmed/22146092 https://www.proquest.com/docview/1010494241 https://www.proquest.com/docview/1034811004 https://www.proquest.com/docview/1733554324 |
| Volume | 61 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB6SDS2FUtr0EfexqNBjvOu318cQGjYtyamB3IRsj4tD1l4qb8he-gP6qztjyRtCm6T0tjYeraSRRt_YM98AfKITl2CB8t2KSe6iAskOkh_hhgWhD5VU2azgbOST02R-Fn05j8-34HDIheGwSmv7jU3vrbW9M7WzOV3WNef4EhYnfM-kZyGh6G3YCcIsiUewc3D8dX66MchMkWYiPch5JoGbRJ7pxWSBHc32pSHz7OO8wruOqKdLpWniKlPx4m5I2h9NR8_hmcWU4sB0-wVsYbMLj0yVyfUuPD6x389fwq_jRlzVV62gjUwGULTXdYlCrxuCgbrW-8KGpgvNce2msMS-UE0plF4vFtgLlTWXnV6TS_ydq0sgCYk2R00NrXJ-raMFv91tV10vyb-FHT9JDxQJr-Ds6PO3w7lrqzG4RZx6nYtxqfI4rZhkzS_6jRulSRyocKbKHPMy9QvCUyrFDDNygyI_LzxFuvYIIuKsCl_DqGkb3ANBKEslMRJyyfyoyqiBNFIJOY4YhHlaJQ5EgwJkYanKuWLGpRxi0i6k7bdkvfFt0psDk43Y0nB1PCSQDNqVQyIqmU5Jp8lDgunfBFFbA6ClL3UgPfnHInVgtpG8tc7_5U_HtxbgZowBuXyM_B34OKxISUaCv_yoBtuV5kaZB4jQ2n3PcE42Ewje80waMj4lEO7AG7Pkb3rBJeK9LHj7_yN8B0_oKjDxpO9h1P1Y4QfCfF0-hu3JT39sd_ZvnSJWgw |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RUB9ShVpK27RAXalHspu3N8cKFS2U5QQSN8tJHBTEJqs6i7qX_oD-6s7Ezq5Qy0O9RYnHsT3j8TfJPAC-4ImLsED6bklJ7qJcoR5EO8INc0QfMinTUU7RyJPTZHweHV_EF2tw0MfCkFul1f1Gp3fa2t4Z2tUczqqKYnwRiyO-p6RnIaLoJ7ARxSEnv77Br5WfByVIM34eaDpj81UYz_BqMFUtrvW1SeXZeXmFdx1QL2dS47KVpt7F3YC0O5gOX8GmRZTsqxn0a1hT9RY8NTUmF1vwbGL_nr-B30c1u6luGobbGNUfa35WhWJ6USMI1JXeZ9YxnWnyajdlJfaZrAsm9WI6VR1RUVHR6QUaxJdUW0IhEWsypbGjeUYfdTSjb7vNvO0o6ZrZ-SN1nyBhG84Pv50djF1bi8HNY-61rooLmcW8pBRrft5t24gncSDDkSwylRXczxFNSa5SlaIRFPlZ7knktIcAUY3K8C2s102t3gNDjCWTWCFuSf2oTLEDHskEzUYVhBkvEweingEit4nKqV7Gteg90q6EHbcgvtFt5JsDgyXZzGTqeIgg6bkr-jBUVJwCz5KHCPm_CJW2218LX-hAeOIvEXVgtKS8JeWPeeneLQFczjFAg49wvwOfe4kUqCLov4-sVTPX1CllAUKsdl8bisim9IH3tOEhoVOE4A68MyK_GgUViPfS4MP_z_ATPB-fTU7EydHp94_wAp8ExrN0B9bbH3O1i-ivzfa63f0HkhJXTg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+vivo+nitric+oxide+synthesis%2C+insulin+sensitivity%2C+and+asymmetric+dimethylarginine+in+obese+subjects+without+and+with+metabolic+syndrome&rft.jtitle=Metabolism%2C+clinical+and+experimental&rft.au=Siervo%2C+Mario&rft.au=Bluck%2C+Les+J.C.&rft.date=2012-05-01&rft.issn=0026-0495&rft.volume=61&rft.issue=5&rft.spage=680&rft.epage=688&rft_id=info:doi/10.1016%2Fj.metabol.2011.10.003&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_metabol_2011_10_003 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00260495%2FS0026049511X00161%2Fcov150h.gif |